Skip to main content
Erschienen in: Rheumatology International 10/2013

01.10.2013 | Original Article

The association of single nucleotide polymorphisms in the calcitonin gene with primary osteoarthritis of the knee in Mexican mestizo population

verfasst von: J. J. Magaña, B. Muñoz, V. M. Borgonio-Cuadra, C. Razo-Estrada, C. González-Huerta, S. Cortés-González, A. Albores, A. Miranda-Duarte

Erschienen in: Rheumatology International | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Primary osteoarthritis (OA) is a multifactorial disorder with several genetics factors involved. Calcitonin (CT) has been suggested to possess chondroprotective effects and could play an important role in the pathogenesis of OA. The aim of this study was to investigate whether genetic variations in or adjacent to the CT gene may be associated with primary OA of the knee in Mexican mestizo population. We conducted a case–control study to investigate the association between six single nucleotide polymorphisms at the CT locus and OA of the knee in 107 cases and 106 controls. Cases were patients >40 years of age, with a body mass index (BMI) ≤27 and a radiologic score for OA of the knee ≥2. Controls were subjects >40 years of age with a radiologic score <2. Non-conditional logistic regression was developed to evaluate risk magnitude. The G allele and GT genotype frequencies of the G-706T polymorphism and the C allele and CC genotype of the C-778T polymorphism were significantly higher in patients with OA than in control subjects. The GG genotype of the G-706T was associated with lower risk of the development of OA of the knee. According to the results, the G-706T and the C-778T polymorphisms were related to the Cdx1 and Mzf1 transcription factor binding sites, respectively. Therefore, these could be related to regulation sequences in the CT gene promoter. In conclusion, G-706T and C-778T polymorphisms in the CT gene are significantly associated with the development of primary OA of the knee.
Literatur
1.
Zurück zum Zitat Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81:646–656PubMed Woolf AD, Pfleger B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81:646–656PubMed
2.
Zurück zum Zitat Haq SA, Davatchi F (2011) Osteoarthritis of the knees in the COPCORD world. Int J Rheum Dis 14:122–129PubMedCrossRef Haq SA, Davatchi F (2011) Osteoarthritis of the knees in the COPCORD world. Int J Rheum Dis 14:122–129PubMedCrossRef
3.
Zurück zum Zitat Katz JN (2006) Total joint replacement in osteoarthritis. Best Pract Res Clin Rheumatol 20:145–153PubMedCrossRef Katz JN (2006) Total joint replacement in osteoarthritis. Best Pract Res Clin Rheumatol 20:145–153PubMedCrossRef
4.
Zurück zum Zitat Michael JW, Schlüter-Brust KU, Eysel P (2010) The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int 107:152–162PubMed Michael JW, Schlüter-Brust KU, Eysel P (2010) The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int 107:152–162PubMed
5.
Zurück zum Zitat Dieppe PA, Lohmander LS (2005) Pathogenesis and management of pain in osteoarthritis. Lancet 365:965–973PubMedCrossRef Dieppe PA, Lohmander LS (2005) Pathogenesis and management of pain in osteoarthritis. Lancet 365:965–973PubMedCrossRef
6.
Zurück zum Zitat Valdes AM, Spector TD (2011) Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol 7:23–32PubMedCrossRef Valdes AM, Spector TD (2011) Genetic epidemiology of hip and knee osteoarthritis. Nat Rev Rheumatol 7:23–32PubMedCrossRef
7.
Zurück zum Zitat Miranda-Duarte A (2012) The genetics of osteoarthritis. In: Rothschilds BM (ed) Principles of osteoarthritis—its definition, character, derivation and modality—related recognition, 1st edn. InTech, Croatia, pp 263–284 Miranda-Duarte A (2012) The genetics of osteoarthritis. In: Rothschilds BM (ed) Principles of osteoarthritis—its definition, character, derivation and modality—related recognition, 1st edn. InTech, Croatia, pp 263–284
8.
Zurück zum Zitat Ikegawa S (2007) New gene associations in osteoarthritis: what do they provide, and where are we going? Curr Opin Rheumatol 19:429–434PubMedCrossRef Ikegawa S (2007) New gene associations in osteoarthritis: what do they provide, and where are we going? Curr Opin Rheumatol 19:429–434PubMedCrossRef
9.
Zurück zum Zitat Magaña JJ, Gálvez-Rosas A, González-Huerta C, Duarte-Salazar C, Lara-Alvarado L, Soria-Bastida MA, Cortés-González S, Miranda-Duarte A (2010) Association of the calcitonin gene (CA) polymorphism with osteoarthritis of the knee in a Mexican mestizo population. Knee 17:157–160PubMedCrossRef Magaña JJ, Gálvez-Rosas A, González-Huerta C, Duarte-Salazar C, Lara-Alvarado L, Soria-Bastida MA, Cortés-González S, Miranda-Duarte A (2010) Association of the calcitonin gene (CA) polymorphism with osteoarthritis of the knee in a Mexican mestizo population. Knee 17:157–160PubMedCrossRef
10.
Zurück zum Zitat Sexton PM, Findlay DM, Martin TJ (1999) Calcitonin. Curr Med Chem 6:1067–1069PubMed Sexton PM, Findlay DM, Martin TJ (1999) Calcitonin. Curr Med Chem 6:1067–1069PubMed
11.
Zurück zum Zitat Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Shea B, Wells G, Adachi J, Waldegger L, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev 23:540–551PubMedCrossRef Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Shea B, Wells G, Adachi J, Waldegger L, Guyatt G (2002) Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr Rev 23:540–551PubMedCrossRef
12.
Zurück zum Zitat Manicourt DH, Devogelaer JP, Azria M, Silverman S (2005) Rationale for the potential use of calcitonin in osteoarthritis. J Musculoskelet Neuronal Interact 5:285–293PubMed Manicourt DH, Devogelaer JP, Azria M, Silverman S (2005) Rationale for the potential use of calcitonin in osteoarthritis. J Musculoskelet Neuronal Interact 5:285–293PubMed
13.
Zurück zum Zitat Papaioannou NA, Triantafillopoulos IK, Khaldi L, Krallis N, Galanos A, Lyritis GP (2007) Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study. Osteoarthr Cartil 15:386–395PubMedCrossRef Papaioannou NA, Triantafillopoulos IK, Khaldi L, Krallis N, Galanos A, Lyritis GP (2007) Effect of calcitonin in early and late stages of experimentally induced osteoarthritis. A histomorphometric study. Osteoarthr Cartil 15:386–395PubMedCrossRef
14.
Zurück zum Zitat Karsdal MA, Byrjalsen I, Henriksen K, Riis BJ, Lau EM, Arnold M, Christiansen C (2010) The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. Osteoarthr Cartil 18:150–159PubMedCrossRef Karsdal MA, Byrjalsen I, Henriksen K, Riis BJ, Lau EM, Arnold M, Christiansen C (2010) The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study. Osteoarthr Cartil 18:150–159PubMedCrossRef
15.
Zurück zum Zitat Behets C, Chappard D, Devogelaer JP, Manicourt DH (2010) Calcitonin prevents the loss of connectivity and complexity of trabecular subchondral bone in early stages of canine osteoarthritis. (Abstract). Osteoarthr Cartil 18(Suppl 2):S52CrossRef Behets C, Chappard D, Devogelaer JP, Manicourt DH (2010) Calcitonin prevents the loss of connectivity and complexity of trabecular subchondral bone in early stages of canine osteoarthritis. (Abstract). Osteoarthr Cartil 18(Suppl 2):S52CrossRef
16.
Zurück zum Zitat Nielsen RH, Bay-Jensen AC, Byrjalsen I, Karsdal MA (2011) Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover. Osteoarthr Cartil 19:466–473PubMedCrossRef Nielsen RH, Bay-Jensen AC, Byrjalsen I, Karsdal MA (2011) Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover. Osteoarthr Cartil 19:466–473PubMedCrossRef
17.
Zurück zum Zitat Sondergaard BC, Wulf H, Henriksen K, Schaller S, Oestergaard S, Qvist P, Tankó LB, Bagger YZ, Christiansen C, Karsdal MA (2006) Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthr Cartil 14:759–768PubMedCrossRef Sondergaard BC, Wulf H, Henriksen K, Schaller S, Oestergaard S, Qvist P, Tankó LB, Bagger YZ, Christiansen C, Karsdal MA (2006) Calcitonin directly attenuates collagen type II degradation by inhibition of matrix metalloproteinase expression and activity in articular chondrocytes. Osteoarthr Cartil 14:759–768PubMedCrossRef
18.
Zurück zum Zitat Karsdal MA, Sumer EU, Wulf H, Madsen SH, Christiansen C, Fosang AJ, Sondergaard BC (2007) Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation. Arthritis Rheum 56:1549–1558PubMedCrossRef Karsdal MA, Sumer EU, Wulf H, Madsen SH, Christiansen C, Fosang AJ, Sondergaard BC (2007) Induction of increased cAMP levels in articular chondrocytes blocks matrix metalloproteinase-mediated cartilage degradation, but not aggrecanase-mediated cartilage degradation. Arthritis Rheum 56:1549–1558PubMedCrossRef
19.
Zurück zum Zitat Karsdal MA, Sondergaard BC, Arnold M, Christiansen C (2007) Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Ann NY Acad Sci 1117:181–195PubMedCrossRef Karsdal MA, Sondergaard BC, Arnold M, Christiansen C (2007) Calcitonin affects both bone and cartilage: a dual action treatment for osteoarthritis? Ann NY Acad Sci 1117:181–195PubMedCrossRef
20.
Zurück zum Zitat Segovia-Silvestre T, Bonnefond C, Sondergaard BC, Christensen T, Karsdal MA, Bay-Jensen AC (2011) Identification of the calcitonin receptor in osteoarthritic chondrocytes. (Abstract). BMC Res Notes 4:407PubMedCrossRef Segovia-Silvestre T, Bonnefond C, Sondergaard BC, Christensen T, Karsdal MA, Bay-Jensen AC (2011) Identification of the calcitonin receptor in osteoarthritic chondrocytes. (Abstract). BMC Res Notes 4:407PubMedCrossRef
21.
Zurück zum Zitat Gorodezky C, Alaez C, Vázquez-García MN, de la Rosa G, Infante E, Balladares S, Toribio R, Pérez-Luque E, Muñoz L (2001) The genetic structure of Mexican mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol 62:979–991PubMedCrossRef Gorodezky C, Alaez C, Vázquez-García MN, de la Rosa G, Infante E, Balladares S, Toribio R, Pérez-Luque E, Muñoz L (2001) The genetic structure of Mexican mestizos of different locations: tracking back their origins through MHC genes, blood group systems, and microsatellites. Hum Immunol 62:979–991PubMedCrossRef
22.
Zurück zum Zitat Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502PubMedCrossRef Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502PubMedCrossRef
23.
Zurück zum Zitat Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
24.
Zurück zum Zitat Hiltunen MO, Koistinaho J, Alhonen L, Myohanen S, Marin S, Kosma VM, Pääkkönen M, Jänne J (1997) Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer. Br J Cancer 76:1124–1130PubMedCrossRef Hiltunen MO, Koistinaho J, Alhonen L, Myohanen S, Marin S, Kosma VM, Pääkkönen M, Jänne J (1997) Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer. Br J Cancer 76:1124–1130PubMedCrossRef
25.
Zurück zum Zitat Monla YT, Peleg S, Gagel RF, Monia YT (1995) Cell type-specific regulation of transcription by cyclic adenosine 3′,5′-monophosphate-responsive elements within the calcitonin promoter. Mol Endocrinol 9:784–793PubMedCrossRef Monla YT, Peleg S, Gagel RF, Monia YT (1995) Cell type-specific regulation of transcription by cyclic adenosine 3′,5′-monophosphate-responsive elements within the calcitonin promoter. Mol Endocrinol 9:784–793PubMedCrossRef
26.
Zurück zum Zitat Buervenich S, Xiang F, Sydow O, Jonsson EG, Sedvall GC, Anvret M, Olson L (2001) Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression. Hum Mutat 17:435–436PubMedCrossRef Buervenich S, Xiang F, Sydow O, Jonsson EG, Sedvall GC, Anvret M, Olson L (2001) Identification of four novel polymorphisms in the calcitonin/alpha-CGRP (CALCA) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression. Hum Mutat 17:435–436PubMedCrossRef
27.
Zurück zum Zitat Goodman MT, Ferrell R, McDuffie K, Thompson PJ, Wilkens LR, Bushley AW, Tung KH, Carney ME, Ness RB (2005) Calcitonin gene polymorphism CALCA-624 (T/C) and ovarian cancer. Environ Mol Mutagen 46:53–58PubMedCrossRef Goodman MT, Ferrell R, McDuffie K, Thompson PJ, Wilkens LR, Bushley AW, Tung KH, Carney ME, Ness RB (2005) Calcitonin gene polymorphism CALCA-624 (T/C) and ovarian cancer. Environ Mol Mutagen 46:53–58PubMedCrossRef
28.
Zurück zum Zitat Morita A, Nakayama T, Soma M, Mizutani T (2007) Association between the calcitonin-related peptide alpha (CALCA) gene and essential hypertension in Japanese subjects. Am J Hypertens 20:527–532PubMedCrossRef Morita A, Nakayama T, Soma M, Mizutani T (2007) Association between the calcitonin-related peptide alpha (CALCA) gene and essential hypertension in Japanese subjects. Am J Hypertens 20:527–532PubMedCrossRef
29.
Zurück zum Zitat Luo XL, Yang TL, Chen XP, Li YJ (2008) Association of CALCA genetic polymorphism with essential hypertension. Chin Med J (Engl) 121:1407–1410 Luo XL, Yang TL, Chen XP, Li YJ (2008) Association of CALCA genetic polymorphism with essential hypertension. Chin Med J (Engl) 121:1407–1410
30.
Zurück zum Zitat Menon S, Buteri J, Roy B, Murrell M, Quinlan S, Macmillan JC, Lea RA, Haupt LM, Griffiths LR (2011) Association study of calcitonin gene-related polypeptide-alpha (CALCA) gene polymorphism with migraine. Brain Res 1378:119–124PubMedCrossRef Menon S, Buteri J, Roy B, Murrell M, Quinlan S, Macmillan JC, Lea RA, Haupt LM, Griffiths LR (2011) Association study of calcitonin gene-related polypeptide-alpha (CALCA) gene polymorphism with migraine. Brain Res 1378:119–124PubMedCrossRef
31.
Zurück zum Zitat Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR, O’Donovan MC (2003) Functional analysis of human promoter polymorphisms. Hum Mol Genet 12:2249–2254PubMedCrossRef Hoogendoorn B, Coleman SL, Guy CA, Smith K, Bowen T, Buckland PR, O’Donovan MC (2003) Functional analysis of human promoter polymorphisms. Hum Mol Genet 12:2249–2254PubMedCrossRef
32.
Zurück zum Zitat Domenech VS, Nylen ES, White JC, Snider RH, Becker KL, Landmann R, Müller B (2001) Calcitonin gene-related peptide expression in sepsis: postulation of microbial infection-specific response elements within the calcitonin I gene promoter. J Invest Med 49:514–521CrossRef Domenech VS, Nylen ES, White JC, Snider RH, Becker KL, Landmann R, Müller B (2001) Calcitonin gene-related peptide expression in sepsis: postulation of microbial infection-specific response elements within the calcitonin I gene promoter. J Invest Med 49:514–521CrossRef
33.
Zurück zum Zitat Margalit Y, Yarus S, Shapira E, Gruenbaum Y, Fainsod A (1993) Isolation and characterization of target sequences of the chicken CdxA homeobox gene. Nucleic Acids Res 21:4915–4922PubMedCrossRef Margalit Y, Yarus S, Shapira E, Gruenbaum Y, Fainsod A (1993) Isolation and characterization of target sequences of the chicken CdxA homeobox gene. Nucleic Acids Res 21:4915–4922PubMedCrossRef
34.
Zurück zum Zitat Beck F, Stringer EJ (2010) The role of Cdx genes in the gut and in axial development. Biochem Soc Trans 38:353–357PubMedCrossRef Beck F, Stringer EJ (2010) The role of Cdx genes in the gut and in axial development. Biochem Soc Trans 38:353–357PubMedCrossRef
35.
Zurück zum Zitat Colleypriest BJ, Palmer RM, Ward SG, Tosh D (2009) Cdx genes, inflammation and the pathogenesis of Barrett’s metaplasia. Trends Mol Med 15:313–322PubMedCrossRef Colleypriest BJ, Palmer RM, Ward SG, Tosh D (2009) Cdx genes, inflammation and the pathogenesis of Barrett’s metaplasia. Trends Mol Med 15:313–322PubMedCrossRef
36.
Zurück zum Zitat Stairs DB, Kong J, Lynch JP (2010) Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia. Prog Mol Biol Transl Sci 96:231–237PubMedCrossRef Stairs DB, Kong J, Lynch JP (2010) Cdx genes, inflammation, and the pathogenesis of intestinal metaplasia. Prog Mol Biol Transl Sci 96:231–237PubMedCrossRef
37.
Zurück zum Zitat Xiao SM, Gao Y, Cheung CL, Bow C, Lau KS, Sham P, Tan KC, Kung AW (2012) Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk. Osteoporos Int. doi:10.1007/s00198-011-1861-1 Xiao SM, Gao Y, Cheung CL, Bow C, Lau KS, Sham P, Tan KC, Kung AW (2012) Association of CDX1 binding site of periostin gene with bone mineral density and vertebral fracture risk. Osteoporos Int. doi:10.​1007/​s00198-011-1861-1
38.
Zurück zum Zitat Bonnet CS, Walsh DA (2005) Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 44:7–16CrossRef Bonnet CS, Walsh DA (2005) Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 44:7–16CrossRef
39.
Zurück zum Zitat Gaboli M, Kotsi PA, Gurrieri C, Cattoretti G, Ronchetti S, Cordon-Cardo C, Broxmeyer HE, Hromas R, Pandolfi PP (2001) Mzf1 controls cell proliferation and tumorigenesis. Genes Dev 15:1625–1630PubMedCrossRef Gaboli M, Kotsi PA, Gurrieri C, Cattoretti G, Ronchetti S, Cordon-Cardo C, Broxmeyer HE, Hromas R, Pandolfi PP (2001) Mzf1 controls cell proliferation and tumorigenesis. Genes Dev 15:1625–1630PubMedCrossRef
40.
Zurück zum Zitat Hromas R, Davis B, Rauscher FJ, Klemsz M, Tenen D, Hoffman S, Xu D, Morris JF (1996) Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1. Curr Top Microbiol Immunol 211:159–164PubMedCrossRef Hromas R, Davis B, Rauscher FJ, Klemsz M, Tenen D, Hoffman S, Xu D, Morris JF (1996) Hematopoietic transcriptional regulation by the myeloid zinc finger gene, MZF-1. Curr Top Microbiol Immunol 211:159–164PubMedCrossRef
41.
Zurück zum Zitat Le Mee S, Fromigue O, Marie PJ (2005) Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res 302:129–142PubMedCrossRef Le Mee S, Fromigue O, Marie PJ (2005) Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res 302:129–142PubMedCrossRef
43.
Zurück zum Zitat Rousset F, Raymond M (1995) Testing heterozygote excess and deficiency. Genetics 140:1413–1419PubMed Rousset F, Raymond M (1995) Testing heterozygote excess and deficiency. Genetics 140:1413–1419PubMed
44.
Zurück zum Zitat Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, Shriver MD (1998) Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 63:1839–1851PubMedCrossRef Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, Forrester T, Allison DB, Deka R, Ferrell RE, Shriver MD (1998) Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 63:1839–1851PubMedCrossRef
45.
Zurück zum Zitat Salari K, Choudhry S, Tang H, Naqvi M, Lind D, Ávila PC, Coyle NE, Ung N, Nazario S, Casal J, Torres-Palacios A, Clark S, Phong A, Gómez I, Matallana H, Pérez-Stable EJ, Shriver MD, Kwok PY, Sheppard D, Rodríguez-Cintron W, Risch NJ, Burchard EG, Ziv E (2005) Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics. Genet Epidemiol 29:76–86PubMedCrossRef Salari K, Choudhry S, Tang H, Naqvi M, Lind D, Ávila PC, Coyle NE, Ung N, Nazario S, Casal J, Torres-Palacios A, Clark S, Phong A, Gómez I, Matallana H, Pérez-Stable EJ, Shriver MD, Kwok PY, Sheppard D, Rodríguez-Cintron W, Risch NJ, Burchard EG, Ziv E (2005) Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics. Genet Epidemiol 29:76–86PubMedCrossRef
46.
Zurück zum Zitat Jiang L, Tian W, Wang Y, Rong J, Bao C, Liu Y, Zhao Y, Wang C (2012) Body mass index and susceptibility to knee osteoarthritis: a systematic review and meta-analysis. Joint Bone Spine 79:291–297PubMedCrossRef Jiang L, Tian W, Wang Y, Rong J, Bao C, Liu Y, Zhao Y, Wang C (2012) Body mass index and susceptibility to knee osteoarthritis: a systematic review and meta-analysis. Joint Bone Spine 79:291–297PubMedCrossRef
47.
Zurück zum Zitat Setakis E, Stirnadel H, Balding DJ (2006) Logistic regression protects against population structure in genetic association studies. Genome Res 16:290–296PubMedCrossRef Setakis E, Stirnadel H, Balding DJ (2006) Logistic regression protects against population structure in genetic association studies. Genome Res 16:290–296PubMedCrossRef
Metadaten
Titel
The association of single nucleotide polymorphisms in the calcitonin gene with primary osteoarthritis of the knee in Mexican mestizo population
verfasst von
J. J. Magaña
B. Muñoz
V. M. Borgonio-Cuadra
C. Razo-Estrada
C. González-Huerta
S. Cortés-González
A. Albores
A. Miranda-Duarte
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 10/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2740-1

Weitere Artikel der Ausgabe 10/2013

Rheumatology International 10/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.